Xenon Pharmaceuticals Inc. (XENE)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.39B |
| Enterprise value | 1.76B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 166.43 |
| Price/book (mrq) | 3.17 |
| Enterprise value/revenue | 133.25 |
| Enterprise value/EBITDA | -16.08 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.36 |
| 52-week change 3 | 38.83% |
| S&P500 52-week change 3 | -9.85% |
| 52-week high 3 | 41.39 |
| 52-week low 3 | 24.94 |
| 50-day moving average 3 | 36.98 |
| 200-day moving average 3 | 34.49 |
Share statistics
| Avg vol (3-month) 3 | 387.79k |
| Avg vol (10-day) 3 | 288.22k |
| Shares outstanding 5 | 62.54M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 57.42M |
| % held by insiders 1 | 1.70% |
| % held by institutions 1 | 95.77% |
| Shares short (12 Jan 2023) 4 | 3.63M |
| Short ratio (12 Jan 2023) 4 | 8.75 |
| Short % of float (12 Jan 2023) 4 | 5.87% |
| Short % of shares outstanding (12 Jan 2023) 4 | 5.80% |
| Shares short (prior month 14 Dec 2022) 4 | 3.82M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Sept 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -840.10% |
Management effectiveness
| Return on assets (ttm) | -13.30% |
| Return on equity (ttm) | -22.66% |
Income statement
| Revenue (ttm) | 13.17M |
| Revenue per share (ttm) | 0.21 |
| Quarterly revenue growth (yoy) | -98.40% |
| Gross profit (ttm) | -57.03M |
| EBITDA | -109.27M |
| Net income avi to common (ttm) | -113.54M |
| Diluted EPS (ttm) | -1.56 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 638.19M |
| Total cash per share (mrq) | 10.2 |
| Total debt (mrq) | 7.16M |
| Total debt/equity (mrq) | 0.95 |
| Current ratio (mrq) | 41.78 |
| Book value per share (mrq) | 12.04 |
Cash flow statement
| Operating cash flow (ttm) | -86.41M |
| Levered free cash flow (ttm) | -53.1M |
© 2023 Yahoo. All rights reserved.
